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The la molecules (HLA-DR, -DP, -DQ in man) are central elements of the
immune system, restricting recognition offoreign antigens to histocompatible T
lymphocytes (1). They are composed of two subunits, a and 0, encoded by the
class II genes of the MHC (2), and by a third subunit, the invariant or y chain
(3), encoded outside the MHC (4). la molecules are genetically polymorphic.
Most of this structural polymorphism is contributed by the 0 chains, and to a
minor extent by the a chains (2).
Although no allelic polymorphism was detected for the invariant chain, several
lines of evidence suggested that alternative protein forms of this molecule are
part of la oligomers. Two-dimensional (2-D)' analyses indicated that, in addition
to spots corresponding to a chains (M,. 34,000), ,B chains (M, 29,000) and to the
principal invariant chain (M, 31,000, hereafter termed 71), other spots could be
consistently detected (5, 6). Two of these spots were shown to be antigenically
related to the yl chain by reactivity with an anti-71 monoclonal antibody, and
were therefore termed y2 and 73 (6). Moreover, an M, 41,000 protein (p41),
also detected as la-associated on 2-D gel is also antigenically related to the yI
chain because of its reactivity with antipeptide antisera produced against 71
(O'Sullivan, unpublished observations). The y2, y3, and p41 proteins could not
be accounted for by posttranslational modifications of the y1 chain, because
their precursors are apparently translated in vitro under conditions in which
posttranslational processing is thought to be absent (6). On the other hand,
isolation of genomic clones and genomic hybridization analyses indicated that y1
chain cDNA probes hybridize to a single-copy gene (7, 8), makingit unlikely that
these proteins are encoded by a family of related genes. The possibility then
remained that these antigenically related forms of invariant chains are encoded
by a single gene through alternative processing of its transcript(s), as we previ-
ously suggested (7). We therefore investigated patterns of splicing, of transcrip-
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' Abbreviation used in this paper:
￿
2-D, two-dimensional.
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tional and translational initiation in transcripts from the invariant chain gene,
which we recently cloned and characterized (7).
In this paper we demonstrate that invariant chain transcripts undergo alternate
splicing and alternate initiation oftranslation. In addition, we mapped a minimum
of three transcriptional start sites in the invariant chain gene, in contrast to
previously reported single start sites (9, 10). We further show that these mecha-
nisms are responsible for the expression of four closely related but structurally
distinct invariant chains from a single gene .
Materials and Methods
Cell Lines.
￿
The human B lymphoblastoid cell lines Raji, 721-P, and LG-2, and the
African green monkey kidney cell line COS-7 were grown in DMEM medium supple-
mented with 10% FCS, glutamine, and antibiotics. They can be obtained from the
American Tissue Culture Collection, Rockville, MD. COS-7 cells support replication at
high copy number of plasmids containing the SV40 origin of replication, since they
express the SV40 large T antigen from an integrated gene (11).
Antisera. The anti-invariant chain murine monoclonal antibody VIC-YI has been
described (6). Rabbit antisera against COON-terminal peptides (C351) of the human yl
chain have also been described elsewhere (12).
cDNA Libraries andPlasmids.
￿
mRNA was isolated from the cell line Raji by oligo-d(T)
chromatography oftotal cytoplasmic RNA (13) obtained by phenol extraction and ethanol
precipitation of detergent-solubilized cells, following removal of nuclei by low-speed
centrifugation. cDNA libraries were constructed in the SV40-based expression vector,
pcD, exactly as described by Okayama and Berg (14). The pcD vector contains the SV40
on region, that permits replication in mammalian cells (14). Expression is directed by
SV40 promoter, splicing, and polyadenylation sequences (14). The cDNA library was
screened by colony hybridization (13), using a 5' Pst I fragment of an invariant chain
partial cDNA clone (15), "P-labeled by nick-translation (13). Positive clones were char-
acterized by restriction mapping and nucleotide sequencing of their 5' ends by the
chemical method (16). Plasmids were purified by the alkaline lysis method (13), followed
by two CsCl gradients (13). The plasmid P371 was constructed by subcloning a human
genomic fragment comprising the entire invariant chain gene (7) in the plasmid pUC9.
Site-directed Mutagenesis.
￿
The plasmid pcDG-I was mutagenized at a single base by the
gapped plasmid method, as described (17). Briefly, the plasmid was either cut with the
restriction endonuclease Cla I, or double cut with Sac II and Xmn I. Single and double
cut plasmids were mixed in a 1 :1 ratio, melted (100°C for 10 min) and then reannealed
in the presence of a 18 by oligonucleotide (see below) in which the G residue of the
second ATG codon was replaced by a C. Incorporation of this oligonucleotide in the
reannealed plasmid resulted in the substitution ofan ATC codon for the ATG (isoleucine
for methionine), and in the creation of a Cla I restriction site (ATCGAT). After repair
with DNA polymerase III, the plasmid mixture was used to transform (13) Escherichia coli
HB101 . Mutant clones were identified by digestion of plasmid DNA minipreps with the
enzyme Cla I . Mutants were found at a frequency of -15% . Nucleotide sequencing (16)
confirmed that the selected clone, pcDG-1 M, contained the desired single-base change.
The oligonucleotide AGCCAGTCATCGATGACC was synthesized on an Applied Bio-
systems (Foster City, CA) automatic synthesizer, according to the instruction manual, and
was purified by polyacrylamide gel electrophoresis (13).
S1 Nuclease Protection Assays. Cytoplasmic poIZ(A)+ RNA from B lymphoid cells,
isolated as described above, was hybridized to a "P-end-labeled (13) Nar I-Bam HI
human genomic fragment comprising the first exon of the invariant chain gene and 600
by upstream. After digestion with S1 nuclease, the mixture was electrophoresed on a
denaturing polyacrylamide gel (6% acrylamide, 0.8 M urea), in parallel with appropriate
sequencing reactions of the same end-labeled fragment. The gel was dried and exposed
on XRP-1 Kodak film. Densitometry of these autoradiograms was performed with an
LKB soft-laser scanner (LKB Instruments, Bromma, Sweden).446
￿
FOUR INVARIANT CHAINS FROM A SINGLE GENE
Transfections, Cell Labeling and Lysis, Immunoprecipitation, and Electrophoresis.
￿
COS-7
cells were transfected by the calcium phosphate precipitation method (18). After 36 h at
37'C, the cells were incubated for 2 h in methionine-free medium containing 0 .1 mCi/ml
[s5S]methionine, then rinsed with saline and detergent lysed as described (6) in 2% of the
nonionic detergent Renex-30 (Accurate Chemical and Scientific Corp., Westbury, NY).
Radiolabeled Raji cell lysates were obtained by the same procedure. Immunoprecipitations
with antibody-protein A-Sepharose immunosorbents were performed as previously re-
ported (6). 2-D nonequilibrium pH gradient electrophoresis (19) and one-dimensional gel
electrophoresis (20) were carried out as published. Gels were fluorographed (21), dried,
and exposed to Kodak XAR-5 film for indicated times.
Results
We constructed cDNA libraries in the simian virus 40 (SV40)-based expression
vector, pcD, described by Okayama and Berg (14), using mRNA isolated from
the human lay lymphoblastoid cell line, Raji. The libraries were screened by
colony hybridization with a yl chain partial cDNA (15) insert. ^-150 positive
colonies were isolated from a single library, with a frequency of ^-1 in 100, in
agreement with the estimated high-abundance of invariant chain-specific mes-
sage (0.5-1%) (6, 15).
Positive clones were rescreened by hybridization to a labeled 5' probe isolated
from the y 1 chain partial cDNA insert. Clones hybridizing to this probe were
characterized by restriction mapping, and those containing the longest inserts
were further analyzed by sequencing their 5' ends. From these analyses, several
putative near-full-length cDNAs were identified. Two types of cDNA clones
were subsequently studied. These differed by an apparent truncation of ^-40 by
at the 5' end. Inserts representative of the first (pcDG-1) and second (pcDG-4)
type are illustrated in Fig. 1 . The relevant feature that distinguished the two
cDNA types was that the longer type contained two 5' ATGs, both in-phase with
the open reading frame, while the other type lacked the 5'-most of these ATGs.
To determine whether either of these ATGs could be used as translational start
sites of distinct proteins, the plasmids were used for transient expression assays
by transfection in the African green monkey kidney cell line, COS-7 . 36 h after
transfection, the cells were metabolically radiolabeled, detergent lysed, and
immunoprecipitated with either monoclonal antibodies or antipeptide antisera
specific for the la yl chain (Fig. 2A) . Upon transfection with pcDG-1, which
contains both AUG codons (AUG/AUG), two bands were immunoprecipitated
(Fig. 2A, lane D), with M, 31,000 and 33,000 respectively, closely resembling
authentic invariant-chain bands from the B lymphoid line Raji (Fig. 2A, lane F).
Only the Mr 31,000 band, however, was immunoprecipitated from cells trans-
fected with a cDNA clone, pcDG-4, which lacks the first AUG (-/AUG) (Fig.
2A, lane C) . Immunoprecipitations with mock-transfected COS-7 cells were
completely negative (Fig. 2A, lane A). Subsequent 2-D analyses indicated that
the proteins expressed from pcDG-1 corresponded to yl, 72, and y3 chains,
while the ones expressed by pcDG-4 corresponded to y 1 chains, since they
comigrated precisely with authentic invariant-chain spots from the B cell line
Raji (Fig. 2B ). These data suggested that, in these cDNA clones, both AUG
codons can be used to initiate translation, giving rise to either y2/y3 or yl
invariant-chain forms.
To directly prove that this was, in fact, the case, plasmids containing the firstO'SULLIVAN ET AL .
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FIGURE 2.
￿
(A) One-dimensional gel electrophoresis analyses ofanti-invariant chain monoclo-
nal antibody VIC-Y1 immunoprecipitates with radiolabeled detergent lysates from either Raji
cells (lane F), or COS-7 cells transfected with the following plasmids : pcDG 1M (ATG/-, lane
E) ; pcDG-1 (ATG/ATG, lane D); pcDG-4 (-/ATG, lane C); p371, which contains the entire
invariant-chain gene (lane B) ; and no-DNA control (lane A) . Film was exposed for 5 d . (B) 2-D
analyses of immunoprecipitates as in lanes C-F from Fig . 2A (clockwise from top left). Film
exposure time was 2 wk,
but not the second AUG were generated by site-directed mutagenesis of the
plasmid pcDG-1 (Fig . 1) . The G residue of the downstream AUG was replaced
with a C, thereby preempting initiation of translation from this codon. This
mutation alters the encoded methionine to an isoleucine, a relatively neutral
change for protein structure . Transfection with the mutagenized plasmid, pcDG-
1M (AUG/-), resulted in expression of y2 and 73, but not 71 chains, asCell line
O'SULLIVAN ET AL.
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TABLE I
Relative Abundance ofInvariant ChainProtein Forms
Raji
COs*
* COS-7 cellstransfected with theplasmidpcDG-1 (AUG/AUG).
indicated by one-dimensional (Fig. 2A, lane E) and 2-D (Fig. 2B) analyses of
anti-invariant chain immunoprecipitates. Together, these results demonstrated
that the downstream AUG is the start site for translation of the principal M,.
31,000 yI chain, and that the first AUG is used to initiate translation of the 'r2
and 73 forms. Note that invariant chains lack a cleavable leader peptide. The
heterogeneity of the M,. 33,000 proteins, generating the y2 and y3 spots, is
probably due to posttranslational modifications (Fig. 2B; and see Discussion).
Although transfections with the plasmid pcDG-I resulted in expression ofboth
y2/y3 and yI chains identical to the ones observed in B cells, the relative ratios
between these invariant chain forms were altered, as indicated by the relative
intensity of y2/y3 and yI bands in Fig. 2A (lanes C-F), and 2-D spots in Fig.
2B. These differences were quantitated by excising bands and/or 2-D spots from
gels, followed by determination ofradioactivity (Table I). In pcDG-I-transfected
cells, the y2/y3 to yl ratio was ^-1.5:1, while in B cells it was ^-5:1 (Table 1).
This higher ratio was not dependent on the cell type used for transfection, since
transfections of COS-7 cells with a cloned human invariant chain chromosomal
gene resulted in y2/y3:yI ratios similar to that ofB cells (Fig. 2A, lane B) (Table
1).
This high frequency of translational start at the second AUG in B cells raised
therefore the possibility that mRNA species lacking the first AUG may exist in
B cells. Thus, we examined the start site(s) for transcription in the human
invariant chain gene by S1 nuclease protection experiments. The strategy for
these assays is detailed in Materials and Methods, and is schematized in Fig. 3.
Results of these experiments, performed with mRNA from three different B
lymphoid lines, revealed three clusters ofprotected fragments, lying at approxi-
mately -5, -10, and -32 by upstream of the first ATG codon of the open
reading frame (Fig. 3). The 2-3 by difference in length amongfragments within
a cluster may be due either to ragged ends generated by the S1 digestion, or
may reflect microheterogeneity in the start sites for transcription. However, for
simplicity, the initiation sites will be referred to as -5, -10, and -32. Even in
long exposures ofthe film, no protected fragments initiating downstream from
the first ATG were detected. These results indicated that, in B cells, all mature
invariant chain mRNA species contain both the AUG codons identified as
yl
Label uptake
y2/y3 p41
Chain
yl :y2/y3
form ratios
yl :p41
cpm
1,881 416 188 4.5 10
2,163 437 153 4.9 14
567 122 68 4.6 8.3
214 134 1.6
239 189 1.3
269 204 1.3450
￿
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FIGURE 3 .
￿
S 1 nuclease protection experiments carried out on a Bam HI-Nar I human
genomic fragment comprising the 5' end of the invariant chain gene (louver right), after
hybridization to mRNA from the B cell lines Raji (1), LG-2 (2), and 721-P (3). The s2P end-
labeled protected fragment were resolved by electrophoresis in denaturing polyacrylamide
gels and visualized by autoradiography . Chemical nucleotide sequencing reactions on the same
labeled fragment were run in parallel lanes . The nucleotide sequence, reversed and comple-
mented, is displayed (top right) . Approximate start points for transcription are underlined, as
the most intense band within each of the three clusters of protected fragments . The two in-
frame ATG (see text) are also underlined. In the lower right part of this figure, the results
are schematized .
potential translation start sites . However, heterogeneityof the 5' termini in these
mRNAs is caused by transcriptional start at three major sites.
To explore the relationship between initiation of transcription at these alter-
nate sites and expression of y2/y3 or yl proteins, the relative abundance of
these mRNA species was determined by densitometric scans of autoradiogramspcDG-1
pcDG-79 j
p41
n
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cca cc g aaa gTA CTG ACC AAG TGC CAG GAA GAG GTC AGC CAC ATC CCT GCT GTC CAC CCG
p41 190 Pro Pro Lys Val Lou Thr Lys Cys Gin Glu Glu Vat Ser His Ile Pro Ala Val His Pro
-yl 190 Pro Pro Lys G
GGT ICA TIC AGG CCC AAG TGC GAC GAG AAC GGC AAC TAT CTG CCA CTC CAG TGC TAT GGG
p41 210 Gly Ser Phe Arg Pro Lys Cys Asp Glu Asn GLy Asn Tyr Leu Pro Lou Gln Cys Tyr Gly
AGC ATC GGC TAC TGC TGG TGT GTC TTC CCC AAC GGC ACG GAG GTC CCC AAC ACC AGA AGC
p41 230 Ser Ile Gly Tyr Cys Trp Cys Val Phe Pro Asn GLy Thr Glu Val Pro Asn Thr Arg Ser
CGC GGG CAC CAT AAC TGC AGT Gag tca ctg gas
250 Arg Gly His His Asn Cys Ser Glu Ser Lou Glu ------------------------280
194
￿
lu Ser Lou Glu ------------------------216
FIGURE 4.
￿
Restriction endonuclease mapofcDNA inserts from plasmids pcDG-1 andpcDG-
79. The thicker lines indicate protein-coding regions. The nucleotide sequence of an extra
coding region found in the pcDG-79 insert is shown in the bottom part of the figure. The
position of this extra region relative to the pcDG-1 insert is marked by thebroken lines. The
location of the extra amino acid stretch within the p41 protein, and its relative position
compared to the y1 protein are also shown. Asterisks mark potential N-linked glycosylation
sites.
of the S1 protected fragments, and compared to the relative ratio of y1 vs.
y2/73 protein (Table I). Integration of the peaks corresponding to the three
clusters of fragments allowed us to estimate that the -5 and the -10 positions
are used ^-40 and -50% of the time, respectively, to initiate transcription, while
the -32 position is used at a lower frequency, ^"10%. Therefore, no simple
correlation was obvious between mRNA ratios (4:6:1) and yl vs. y2/73 ratio
(5:1) (Table I).
Restriction mappingofourinvariantchain cDNA clones revealed that 7 inserts
out of 66 contained a common extra Sma I-Pst I restriction fragment, not seen
in pcDG-1, a prototype near-full-length 71 chain cDNA (Fig. 4). Out of these
seven cDNAs, the longest one (pcDG-79) was completely sequenced, confirming
that it contained an additional 192 by of coding sequence precisely interjected
between the last basepairs ofexons 6 and the first nucleotides ofexon 7 (Fig. 4).
Comparison of the restriction map of clone pcDG-79 with that of a previously
characterized (7) phage clone containing the invariant chain chromosomal gene,
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FIGURE 5 .
￿
Location of exon X in the invariant chain gene, as determined by restriction
mapping and nucleotide sequencing . Nucleotide sequences of the 5' and 3' border of this
exon are shown to indicate their compliance to the splicing acceptor/donor consensus se-
quences.
allowed us to identify a similar Sma I-Pst I restriction fragment, located as
expected in the intron separating exons 6 and 7 . This fragment was sequenced
(16) together with its flanking regions, revealing it to contain a 192 by coding
sequence identical to the extra fragment ofthe pcDG-79 cDNA insert . Sequences
conforming to the canonical AG/GT splice consensus sequences were found
both at the 5' and the 3' boundaries of this exon (Fig . 5) .
To correlate alternative splicing of this extraexon (exon X) with the generation
ofan invariant chain-like protein in B cells, theplasmid pcDG-79 was transfected
in COS-7 cells. Immunoprecipitation with anti-invariant chain antisera followed
by 2-D electrophoresis revealed a protein with electrophoretic mobility identical
to the previously observed, la-associated p41 component from aB lymphoid cell,
Raji (Fig . 6) . Two additional spots, whose relative mobility to the p41 was similar
to the relative mobility of 72/73 to the y l spot, were also observed in these
immunoprecipitations (Fig . 6, vertical arrows) . They are probably accounted for
by the fact that the pcDG-79 clone is nearly full length, contains both 5' AUGs,
and translation initiates at either ofthem . These results demonstrate that the la-
associated p41 protein is derived from the invariant-chain gene by a mechanism
of alternative exon splicing, and therefore bears a close structural relationship
to the la 71 chain.
The extra exon (exon X) of the p41 encodes a stretch of 64 amino acids
(shown in Figs . 4 and 7) . This sequence includes six cysteines, and does not
resemble any other part of the y 1 chain . It contains two additional sites, Asn-
Gly-Thr and Asn-Cys-Ser, that could be used for NI-I2-linked glycosylation (Fig .
4) . A computer search of the Genbank database with the program DFASTP (22)
identified amino acid homology, with a repeating unit found in bovine andO'SULLIVAN ET AL .
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Human
Thyroglobulin 299 TKC. .EVERFTATSFGHPYVPSCRRNGDYQAVQC .QTEGPCWCVDAQGKE 345
p41
￿
3 TKCHEEVSHIPAVHPGSFR .PKCDENGNYLPLQCYGSIGYCWCVFPNGTE 51
Bovine
Thyroglobulin 670 SLLGSQPAGSSLFVPACTSKGNFLPVQCFNS . .ECYCVDTEGQPIPGTR 716
p41
￿
LO SHIPAVHPGS . .FRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTR 56
Consensus
￿
CPTXCE 12-27 FXPQC 3 GXF 2 VQC 4-6 CWCVD 2 GXE 2 GTR 6-8
p41
￿
VLTKCH 14
￿
FRPKC 3 GNY 2 LQC 6 CWCVF 2 GTE 2 NTR 6
FIGURE 7.
￿
Homology of the p41 amino acid sequence encoded by exon X with regions of
human (37) and bovine (38) thyroglobulin. The homology regions correspond to a sequence
imperfectly repeated 10 times in thyroglobulin. The repeats that scored highest in the
computer search are shown. In addition, a consensus sequence derived from the repeats of
human thyroglobulin precursor is shown at the bottom line. Cysteine residues are in italics.
Numberingindicates position of the sequences shown in the respective proteins.
human thyroglobulin (Fig. 7). The statistical significance of this homology was
confirmed by random shuffling using the program RDF (22). The calculated Z
values of the scores were 16.1 and 11 .9, respectively, for human and bovine
thyroglobulin (Z > 3, possibly significant; Z > 6, probably significant; Z > 10,
significant). Similar results were obtained with a different algorithmn, WORD-
SEARCH (University of Wisconsin Genetics Computer Group, Madison, WI).
Discussion
To contribute to the understanding of the molecular mechanisms controlling
la-restricted recognition ofantigen, we investigated some structural properties
of a nonpolymorphic human la subunit, the invariant chain. The experiments
presented here show the existence of a complex pattern of transcription and
transcript processing in its corresponding gene, resulting in the expression of
four invariant chain forms (yl, y2/,y3, p41, and p43), all associated with la
oligomers and potentially of distinct functional significance. First, transcription
of the gene initiates a minimum of three sites. Second, the primary transcripts
are alternatively spliced to include or exclude one of the protein-coding exons.
Third, two AUGs are alternatively used to initiate translation in the mature
mRNAs.
Transcriptional start at more than one site is consistent with the absence in
the invariant chain gene of a conventional TATA box (7), which is believed to
accurately position the initiation site (23, 24). Other sequences, less efficient than
TATA boxes, may act as promoters for multiple start sites in the invariant chain
gene, as proposed for Xenopus histone (24) and adenovirus (25) genes. Another
formal possibility is that the 5' terminus of a single transcript is differentially
cleaved posttranscriptionally, but this is very unlikely since no enzymes capable
of performing this function are known (24, 25). The heterogeneity of 5' termini
in the invariant chain mRNAs is of critical importance to interpret another
mechanism observed, alternate initiation of translation (see below). Our results
contrast with previous reports ofone single site for initiation oftranscription inO'SULLIVAN ET AL.
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the same gene (9, 10). The reasons for such discrepancy are unclear, since actual
data of S1 protection experiments were not included in those reports.
Besides this heterogeneity of 5' termini, distinct mRNAs are also generated
from the invariant chain gene by a mechanism of alternate splicing ofan internal
coding exon. This exon (termedexon X) is 192 by long, and becomes the longest
of the coding exons in the invariant chain gene (7). Although its 5' and 3'
boundaries conform to the AG/GT rule (26) for acceptor and donor splice sites,
they are used ^-10% of the time as determined by frequency of exon X-
containing cDNAs in two libraries we screened. Differential frequency of usage
for apparently functional splice sites is a well-known phenomenon in eukaryotes,
but the factors governing it are not understood (27). There are also several
precedents in eukaryotes for alternate splicing ofprimary transcripts, giving rise
to messages encoding two or more proteins from a single gene. In several' of
these cases, the alternate splicing is regulated in either a tissue-specific (28, 29)
or developmental (29, 30) fashion. It will be of interest to determine whether
this is true for the invariant chain gene. The relative abundance of yl and p41
approximated a ratio of 10:1 (Table I), but showed some variability that could
reflect different turnover rates forthese two proteins (V. Quaranta, unpublished
observations).
Both types of alternatively spliced invariant chain mRNAs contain two func-
tional start sites for translation, placed in-frame and 48 by apart, that can be
alternatively used to synthesize two proteins differing by a 16-amino-acid NH2-
terminal segment of M, 33,000 and 31,000, respectively. Exon X-containing
mRNAs give rise, instead, to proteins ofM, 43,000 and 41,000 . Reactivity with
anti-invariant chain antisera and 2-D mobility revealed that these proteins were
identical to Ia-associated proteins, namely -yl (M, 31,000), y2/y3 (M,. 33,000)
and p41 (M,. 41,000), isolated from B cells. Spots corresponding to theM, 43,000
proteins, previously unnoticed in la immunoprecipitates, can also be seen in
overexposed autoradiograms of la immunoprecipitates from B cells (Fig. 6,
vertical arrows).
The high yl:y2/y3 ratio in B lymphoid cells (5:1, Table 1) may imply
downregulation of the first AUG as a start site. Although the factors regulating
initiation of translation are not completely understood, mRNA nucleotide se-
quences near the 5' terminus are thought to play an important role (31). A
comparison of sequence contexts of known translational start sites revealed a
consensus sequence (CCG/ACCAUGG) surrounding them (32). The occurrence
ofthis consensus around the second but not the first ofthe invariant chain AUGs
(Fig. 1) may explain the lower usage ofthe latter. Another possibility is that the
different lengths of 5' untranslated leaders resulting from the heterogeneous
transcriptional start sites may affect usage ofthe first ATG. Untranslated leaders
are thought to contain sequences that provide binding sites for ribosomes and
initiation factors (33). Because the structural requirements ofthese binding sites
in eukaryotesare notknown, it is difficultto make predictions from the sequences
ofthe invariant chain mRNA 5' termini. In vitro translation ofappropriate RNA
constructs might be used to distinguish among these possibilities. It should also
be noted that differential stability of the two mRNA products, or differences in456
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the turnover rates ofthe encoded proteins mightalso contribute to the observed
yl:y2/y3 ratios.
It will be interesting to determine whether, in any of these mRNA species
distinguishedby their 5' termini, translation initiatesalternatively ateither AUG,
so that the same message gives rise to two proteins of nonidentical primary
structure. Examples of this kind were previously described in certain eukaryotic
viruses, which generate as many as three proteins from a single message (34). In
spite ofseveral studies, such strategy could never be demonstrated for constitu-
tive cell messages (35), and the invariant chain mRNA could be the first such
example. Strubinet al. addressed this issue in a recent study(9), but unfortunately
did not recognize the heterogeneity of invariant-chain 5' termini and did not
therefore test critical mRNA constructs. Artificial examples of translational
initiation at internal AUGs were recently prepared by inserting multiple ATGs
in front of mammalian genes cloned in SV40-based expression vectors (35, 36).
Indeed, the plasmid pcDG-1, described in this study, could be classified with this
group. However, the fact that, in cells transfected with pcDG-1 the relative usage
ofthe first and second in-frame AUGs is much different than in B cells cautions
against uncritically extending data from such cloned cDNAs to constitutive
mRNAs. In this context, the human invariant chain mRNA could be an inter-
esting model for regulation oftranslational initiation at internal AUGs in consti-
tutive cell messages.
Cumulatively, these results established the molecular basis for the presence of
structurally distinct, antigenically related invariant chains in la oligomers. The
structural features that distinguish the four protein forms ofinvariant chain can
be summarized as follows, taking the predominant, Mr 31,000 yl chain form as
the prototype invariant chain.
The y2/y3 forms, translated from the first in-frame AUG codon of exon X-
lacking mRNAs, are structurally identical to the y1 form, except for a 16-amino-
acid NH2-terminal segment, ofvery basic overall character. Becausethe invariant
chains lack a cleavable signal sequence (15, 37), andbecause theirtransmembrane
orientation is with NH2 terminus facing the cytoplasm (15), this results in the
y2/y3 forms having a longer (46 as opposed to 30 residues) and more basic
cytoplasmic tail than the y 1 chain, which may mediate different types of func-
tional interactions. In this regard, we recently determined that the y1, but not
the y2/y3 proteins is phosphorylated at their cytoplasmic tail in several cell types
(R. Spiro and V. Quaranta, unpublished observations). Similar relationships
could be valid for the p43 and p4l forms. Transfections with the plasmid pcDG-
1M, which contained a single ATG translational start site, clearly indicated that
the y2 and y3 proteins are translated with identical amino acid sequences. Their
differential 2-D mobility, i.e., two spots with identical relative molecular mass
and distinct pI each accompanied by slightly more acidic satellite spots (Fig. 2B),
strongly suggests that they are distinguished by a posttranslational modification
introducing charges.
The p4l form, generated by the splicing-in of exon X, contains 64 amino
acids more than the y1 form, and is otherwise identical to it. This stretch of
amino acids, located near the COOH terminus, contains six cysteines, while the
remainder of the protein has only one. Such unusual concentration ofcysteinesO'SULLIVAN ET AL.
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suggests a tight globular structure ofthis extra domain, and a possible involve-
ment in the formation of disulfide-bridged dimers or multimers. An overall
homology at the amino acid level of >40% was found between this segment and
a region of similar length that is repeated 10 times in human (38) and bovine
thyroglobulin (39). The similarity is made more significant by the virtually
absolute conservation of the cysteine spacing patterns, as observed for other
protein families (40). Interestingly, the repeat units of thyroglobulin are likely
encoded by discrete exons (39). Therefore, the evolutionary mechanism that
generated this homology may be one of intergenic exon shuffling (41). The
biological significance and possible functional implications of this finding are
unknown.
All ofthe invariant chain forms described here are part of la oligomers, since
they are found in la molecules isolated with anti-,B chain antisera. However, it
remains to be seen at what stage the various invariant chain forms associate to
la oligomers, and whether they display preference of association with a or ,B
chains ofthe DR, DP, or DQseries . The stoichiometric ratios ofthese interactions
also need to be determined. Variations of this kind in the composition of Ia
molecules may well have functional implications. If so, it may be possible to
understand the strategic significance of encoding four different proteins in a
single gene rather than duplicated genes.
Summary
We determined the structural basis for the presence of electrophoretically-
distinct, antigenically-related forms of invariant chains in la oligomers, and
established the mechanisms by which they can be expressed from a single gene.
S1 nuclease protection assays indicated that, in B cells, transcription ofthis gene
initiates at a minimum ofthree sites. Thus, unlike previously thought, invariant
chain mRNAs have heterogeneous 5' untranslated segments that may differen-
tially affect initiation of translation. Further, restriction mapping and nucleotide
sequencing ofcDNAs revealed two kinds ofinvariant chain mRNAs differingby
an internal coding segment of 192 bp. This segment represents an alternatively
spliced exon, as demonstrated by nucleotide sequencing of corresponding ge-
nomic regions. The exon (exon X) encodes a cysteine-rich stretch of 64 amino
acids near the COOH terminus that displays a striking and surprising homology
to an internal amino acid repeat of thyroglobulin, suggesting an evolutionary
mechanism of exon shuffling. Transient expression of cDNAs indicated that
both types ofalternatively spliced mRNAs contain two in-frame AUGs function-
ing as alternate start sites for translation. Thus, transfections with exon X-
lacking cDNAs resulted in the expression of M,. 33,000 and 31,000 proteins,
detectedby immunoprecipitation withanti-invariant chainantisera,andidentical
by two-dimensional gel (2-D) analyses to the B cell invariant-chain forms 71 (M,.
31,000), 72, and 73 (M,. 33,000). Similarly, exon X-containing cDNAs expressed
M, 43,000 and 41,000 proteins, also identical by 2-D migration to la-associated
proteins. Thus, human la molecules contain four forms of invariant chain of
closely related but nonidentical primary structure that are generated from a
single gene by a complex pattern ofalternate transcriptional start, exon splicing,
and translational start.458
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